ABBV vs ASML: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and ASML Holding N.V. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
ASML Holding N.V. · Technology
$1,744.61
-0.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
ASML has more upside to fair value
(-0.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ASML |
| Current Price |
$261.70 |
$1,744.61 |
| Fair Value Estimate |
$259.04 |
$1,732.49 |
| Upside to Fair Value |
-1.0%
|
-0.7%
|
| Market Cap |
$462.4B |
$672.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
42.0x
|
| Price / Sales |
7.2x
|
19.0x
|
| Price / FCF |
23.6x
|
67.2x
|
| Revenue Growth YoY |
+10.2%
|
+21.3%
|
| Gross Margin |
71.5%
|
52.7%
|
| Operating Margin |
29.3%
|
35.4%
|
| Return on Equity |
-136.5%
|
52.4%
|
| Dividend Yield |
2.61% |
0.51% |
| FCF Yield |
4.25%
|
1.49%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
ASML Holding N.V. is the Dutch semiconductor equipment maker that supplies lithography, metrology, and inspection systems, including the extreme ultraviolet (EUV) machines required to pattern the most advanced logic and memory chips, and it holds what current coverage describes as a near-monopoly on those EUV tools. The business quality is genuinely high: TTM gross margin of 52.7%, TTM operating …
Accumulation Zones
| Metric |
ABBV |
ASML |
| Zone Low |
$194.28 |
$1,299.37 |
| Zone High |
$220.18 |
$1,472.62 |
| In Buy Zone? |
No
|
No
|